COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00640159
Brief Title: Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease

First Submitted : March 18, 2008
First Submitted that Met QC Criteria : March 20, 2008
First Posted : March 21, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : March 12, 2009
Last Update Posted : March 16, 2009 (Estimate)